Yulia Rubanova
Overview
Explore the profile of Yulia Rubanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerstung M, Jolly C, Leshchiner I, Dentro S, Gonzalez S, Rosebrock D, et al.
Nature
. 2023 Jan;
614(7948):E42.
PMID: 36697833
No abstract available.
2.
Rubanova Y, Shi R, Harrigan C, Li R, Wintersinger J, Sahin N, et al.
Nat Commun
. 2022 Dec;
13(1):7567.
PMID: 36482170
No abstract available.
3.
Dentro S, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar A, et al.
Cell
. 2021 Apr;
184(8):2239-2254.e39.
PMID: 33831375
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin, and drivers of ITH across cancer types are poorly understood. To...
4.
Gerstung M, Jolly C, Leshchiner I, Dentro S, Gonzalez S, Rosebrock D, et al.
Nature
. 2020 Feb;
578(7793):122-128.
PMID: 32025013
Cancer develops through a process of somatic evolution. Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and...
5.
Rubanova Y, Shi R, Harrigan C, Li R, Wintersinger J, Sahin N, et al.
Nat Commun
. 2020 Feb;
11(1):731.
PMID: 32024834
The type and genomic context of cancer mutations depend on their causes. These causes have been characterized using signatures that represent mutation types that co-occur in the same tumours. However,...
6.
Harrigan C, Rubanova Y, Morris Q, Selega A
Pac Symp Biocomput
. 2019 Dec;
25:238-249.
PMID: 31797600
Mutational signatures are patterns of mutation types, many of which are linked to known mutagenic processes. Signature activity represents the proportion of mutations a signature generates. In cancer, cells may...
7.
Espiritu S, Liu L, Rubanova Y, Bhandari V, Holgersen E, Szyca L, et al.
Cell
. 2018 Apr;
173(4):1003-1013.e15.
PMID: 29681457
The majority of newly diagnosed prostate cancers are slow growing, with a long natural life history. Yet a subset can metastasize with lethal consequences. We reconstructed the phylogenies of 293...